T-cell immune function in psoriatic patients as regards release of Interleukin-2

ABSTRACT

Levels of interleukin-2 were estimated [using the radioimmunoassay technique] in sera of patients suffering from chronic plaque type psoriasis vulgaris with moderate disease activity and without arthropathy. All patients were receiving non-steroidal topical treatment. Ten healthy volunteers were used as the control group. Our results showed non-significant changes as compared with the control group. These data showed that there is no systemic alteration of intreleukin-2 our psoriatic patients